Clinical Trials Browser

Phase 1/2 × Suspected Central Nervous System Tumors × Clear all

NCT02710240 2021-10-27

Indocyanine Green for Central Nervous System Tumors

Phase 1/2 Completed

336 enrolled 7 charts

Suspected Central Nervous System Tumors